TG Therapeutics, Inc. (TGTX)
55.18
-0.91
(-1.62%)
USD |
NASDAQ |
Sep 02, 11:32
TG Therapeutics Net Income (TTM) : 441.49M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 441.49M |
| March 31, 2026 | 461.90M |
| December 31, 2025 | 447.18M |
| September 30, 2025 | 447.47M |
| June 30, 2025 | 60.46M |
| March 31, 2025 | 39.15M |
| December 31, 2024 | 23.38M |
| September 30, 2024 | -14.36M |
| June 30, 2024 | 95.69M |
| March 31, 2024 | 41.20M |
| December 31, 2023 | 12.67M |
| September 30, 2023 | -25.91M |
| June 30, 2023 | -175.65M |
| March 31, 2023 | -168.55M |
| December 31, 2022 | -198.34M |
| September 30, 2022 | -238.68M |
| June 30, 2022 | -288.50M |
| March 31, 2022 | -326.48M |
| December 31, 2021 | -348.10M |
| September 30, 2021 | -342.98M |
| June 30, 2021 | -344.51M |
| March 31, 2021 | -318.89M |
| December 31, 2020 | -279.38M |
| September 30, 2020 | -230.74M |
| June 30, 2020 | -205.50M |
| Date | Value |
|---|---|
| March 31, 2020 | -188.83M |
| December 31, 2019 | -172.87M |
| September 30, 2019 | -187.16M |
| June 30, 2019 | -159.18M |
| March 31, 2019 | -167.11M |
| December 31, 2018 | -173.48M |
| September 30, 2018 | -150.48M |
| June 30, 2018 | -148.07M |
| March 31, 2018 | -132.28M |
| December 31, 2017 | -118.48M |
| September 30, 2017 | -111.29M |
| June 30, 2017 | -104.59M |
| March 31, 2017 | -92.13M |
| December 31, 2016 | -78.25M |
| September 30, 2016 | -72.19M |
| June 30, 2016 | -61.02M |
| March 31, 2016 | -62.22M |
| December 31, 2015 | -62.95M |
| September 30, 2015 | -64.13M |
| June 30, 2015 | -67.93M |
| March 31, 2015 | -62.81M |
| December 31, 2014 | -55.78M |
| September 30, 2014 | -42.65M |
| June 30, 2014 | -29.75M |
| March 31, 2014 | -24.35M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Krystal Biotech, Inc. | 241.46M |
| MAIA Biotechnology, Inc. | -26.85M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| BioMarin Pharmaceutical, Inc. | 72.97M |
| Cytokinetics, Inc. | -894.00M |